T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope

Journal of Virology

Volumn 83, Issue 18, 2009, Pages 9206-9214

  Wahl, Angela ^a   McCoy, William ^b   Schafer, Fredda ^a   Bardet, Wilfried ^a   Buchli, Rico ^c   Fremont, Daved H ^b   Hildebrand, William H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pure Protein LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC VARIABILITY; IMMUNOLOGICAL TOLERANCE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRUS GENE; VIRUS MUTATION;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CROSS-PRIMING; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MUTATION, MISSENSE; RNA-BINDING PROTEINS; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 69449091851     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00932-09     Document Type: Article

References (38)

1. Bao, Y., P. Bolotov, D. Dernovoy, B. Kiryutin, L. Zaslavsky, T. Tatusova, J. Ostell, and D. Lipman. 2008. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 82:596-601.
2. Beekman, N. J., P. A. van Veelen, T. van Hall, A. Neisig, A. Sijts, M. Camps, P. M. Kloetzel, J. J. Neefjes, C. J. Melief, and F. Ossendorp. 2000. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 164:1898-1905.
3. Berkhoff, E. G., A. C. Boon, N. J. Nieuwkoop, R. A. Fouchier, K. Sintnicolaas, A. D. Osterhaus, and G. F. Rimmelzwaan. 2004. A mutation in the HLA-B* 2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J. Virol. 78:5216-5222.
4. Berkhoff, E. G., E. de Wit, M. M. Geelhoed-Mieras, A. C. Boon, J. Symons, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2005. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J. Virol. 79:11239-11246.
5. Berkhoff, E. G., E. de Wit, M. M. Geelhoed-Mieras, A. C. Boon, J. Symons, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2006. Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses. Vaccine 24:6594-6596.
6. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933-943.
7. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, C. H. Linde, J. V. Chisholm, 3rd, T. M. Zaman, E. Pae, S. Mallal, B. D. Walker, A. Sette, B. T. Korber, D. Heckerman, and C. Brander. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176:4094-4101.
8. Boon, A. C., G. de Mutsert, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2006. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. J. Virol. 80:6024-6032.
9. Boon, A. C., G. de Mutsert, Y. M. Graus, R. A. Fouchier, K. Sintnicolaas, A. D. Osterhaus, and G. F. Rimmelzwaan. 2002. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J. Virol. 76:582-590.
10. Boon, A. C., G. de Mutsert, Y. M. Graus, R. A. Fouchier, K. Sintnicolaas, A. D. Osterhaus, and G. F. Rimmelzwaan. 2002. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J. Virol. 76:2567-2572.
11. Buchli, R., R. S. Vangundy, C. F. Giberson, and W. H. Hildebrand. 2006. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. J. Immunol. Methods 314:38-53. (Pubitemid 44189427)
12. Buchli, R., R. S. VanGundy, H. D. Hickman-Miller, C. F. Giberson, W. Bardet, and W. H. Hildebrand. 2004. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry 43:14852-14863. (Pubitemid 39524960)
13. Buchli, R., R. S. VanGundy, H. D. Hickman-Miller, C. F. Giberson, W. Bardet, and W. H. Hildebrand. 2005. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A* 0201 - a new tool for epitope discovery. Biochemistry 44:12491-12507. (Pubitemid 41324340)
14. de Campos-Lima, P. O., V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297-1305.
15. De Groot, A. S., A. Bosma, N. Chinai, J. Frost, B. M. Jesdale, M. A. Gonzalez, W. Martin, and C. Saint-Aubin. 2001. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 19:4385-4395.
16. Hillig, R. C., M. Hulsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler. 2004. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 279:652-663.
17. Hollsberg, P. 2002. Contribution of HLA class I allele expression to CD8 T-cell responses against Epstein-Barr virus. Scand. J. Immunol. 55:189-195.
18. Hourigan, C. S., M. Harkiolaki, N. A. Peterson, J. I. Bell, E. Y. Jones, and C. A. O'Callaghan. 2006. The structure of the human allo-ligand HLA-B* 3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition. Eur. J. Immunol. 36:3288-3293.
19. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, P. Zimbwa, S. Moore, T. Allen, C. Brander, M. M. Addo, M. Altfeld, I. James, S. Mallal, M. Bunce, L. D. Barber, J. Szinger, C. Day, P. Klenerman, J. Mullins, B. Korber, H. M. Coovadia, B. D. Walker, and P. J. Goulder. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775.
20. Martin, W., H. Sbai, and A. S. De Groot. 2003. Bioinformatics tools for identifying class I-restricted epitopes. Methods 29:289-298. (Pubitemid 36513445)
21. McMichael, A. J., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367-1371.
22. Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61:403-407.
23. Milicic, A., D. A. Price, P. Zimbwa, B. L. Booth, H. L. Brown, P. J. Easterbrook, K. Olsen, N. Robinson, U. Gileadi, A. K. Sewell, V. Cerundolo, and R. E. Phillips. 2005. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J. Immunol. 175:4618-4626. (Pubitemid 41362001)
24. Rimmelzwaan, G. F., A. C. Boon, J. T. Voeten, E. G. Berkhoff, R. A. Fouchier, and A. D. Osterhaus. 2004. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res. 103:97-100.
25. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
26. Roder, G., T. Blicher, S. Justesen, B. Johannesen, O. Kristensen, J. Kastrup, S. Buus, and M. Gajhede. 2006. Crystal structures of two peptide-HLA-B* 1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr. D 62:1300-1310. (Pubitemid 44637074)
27. Rohrlich, P. S., S. Cardinaud, H. Firat, M. Lamari, P. Briand, N. Escriou, and F. A. Lemonnier. 2003. HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. Int. Immunol. 15:765-772.
28. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212. (Pubitemid 30099525)
29. Smith, K. D., B. E. Mace, A. Valenzuela, J. L. Vigna, J. A. McCrutcheon, J. A. Barbosa, E. Huczko, V. H. Engelhard, and C. T. Lutz. 1996. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J. Immunol. 157:2470-2478.
30. Soudeyns, H., S. Paolucci, C. Chappey, M. B. Daucher, C. Graziosi, M. Vaccarezza, O. J. Cohen, A. S. Fauci, and G. Pantaleo. 1999. Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur. J. Immunol. 29:3629-3635.
31. Stewart-Jones, G. B., A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 2003. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4:657-663.
32. Voeten, J. T., T. M. Bestebroer, N. J. Nieuwkoop, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2000. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J. Virol. 74:6800-6807.
33. Voeten, J. T., G. F. Rimmelzwaan, N. J. Nieuwkoop, R. A. Fouchier, and A. D. Osterhaus. 2001. Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells. Clin. Exp. Immunol. 125:423-431.
34. Wahl, A., F. Schafer, W. Bardet, R. Buchli, G. M. Air, and W. H. Hildebrand. 2009. HLA class I molecules consistently present internal influenza epitopes. Proc. Natl. Acad. Sci. USA 106:540-545.
35. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755-2759.
36. Yewdell, J., J. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637-640. (Pubitemid 18066227)
37. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3:1177-1184.
38. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.